{
 "PrintNo":"A8197","Session":2023,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2023-10-27T10:53:49.880448Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2024-01-03","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2023-10-27","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2024-01-03","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":673,"Name":"Michaelle C. Solages","Short":"SOLAGES"}],
 "Title":"Requires clinical trials that apply for state grant funding to make certain information about such clinical trials public",
 "Summary":"Requires any sponsor of a clinical trial in this state, including but not limited to, a pharmaceutical drug manufacturer, pharmaceutical drug wholesaler, academic medical center, voluntary group, federal agency or health care provider, that applies for a state grant to conduct such clinical trial, to conspicuously post certain information about such clinical trial on the department's website.",
 "LawSection":"Public Health Law","LawCode":"Add Art 2 Title 9 §§269-b - 269-d, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to requiring clinical trials that apply for state grant funding to make certain information about such clinical trials public",
 "SameAsPrintNo":"S1523-2023","PreviousVersions":["A9331-2021"]
}